pharmaphorum January 22, 2021
Catherine Longworth

As Joe Biden takes the reins at the White House, pharmaphorum asks experts how his presidential tenure may influence the global healthcare industry.

“I think the Biden administration will have only an incremental impact on the healthcare industry as a whole,” said Maxim Jacobs, CFA, managing partner and director of research at Edison Group.

“With a slim majority in the House and an evenly divided Senate it will be tough for him to get anything radical through Congress. He ran on protecting and expanding Obamacare and I think that is probably what he will try to do. He’ll be able to protect it but I’m not sure about his ability to expand it or enact things like the public option.”

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma / Biotech, Provider
A.C.C.E.S.S. AI: A New Framework For Advancing Health Equity In Health Care AI
Navigating COVID: a journey from academic intensity to healing
U.S. Birth Rate Drops To New Low After Pandemic ‘Baby Bump’
Covid-19 Vaccination Associated With Reductions In Pediatric Cases & Hospitalizations
Genetics Studies Have a Diversity Problem That Researchers Struggle To Fix

Share This Article